CAR T- cell therapy: A promising novel approach for treatment of cancer [0.03%]
CAR-T细胞疗法——癌症治疗的新型方法
Mahesh Kumar Posa,Jyoti Singh,Sadia Parveen et al.
Mahesh Kumar Posa et al.
Chimeric Antigen Receptor T-cell (CAR-T cell) therapy is a promising cancer treatment that has shown success in treating certain type of cancer. It has demonstrated remarkable efficacy, particularly in hematologic malignancies such as certa...
Precision oncology in Bulgaria: a prospective study of metastatic colorectal cancer patients [0.03%]
保加利亚的精准肿瘤学：转移性结直肠癌患者前瞻性研究
George Dimitrov,Zornitsa Kamburova,Krassimir Petrov et al.
George Dimitrov et al.
Background: Geographic disparities in access to molecular diagnostics and targeted therapies affect the implementation of precision oncology in metastatic colorectal cancer (mCRC), particularly in Eastern Europe. This pro...
A predictive nomogram for cancer-specific survival in elderly patients with ductal carcinoma in situ after lumpectomy: A SEER-based retrospective study [0.03%]
基于SEER数据库的乳腺导管原位癌老年患者保乳术后癌症特异性生存预测列线图的建立：回顾性研究
Hui Hongxia,Luo Honglei,Ren Yi et al.
Hui Hongxia et al.
Purpose: To develop and validate a prognostic nomogram to predict cancer-specific survival (CSS) in elderly patients with ductal carcinoma in situ (DCIS) following breast-conserving surgery (BCS). ...
The association between greenness, walkability, and post-menopausal breast cancer risk in Alberta's Tomorrow Project [0.03%]
艾伯塔明天计划中绿化程度、步行友好度与绝经后乳腺癌风险之间的关联性研究
Mohadeseh Ahmadi,Rachel A Murphy,Maryam Darvishian et al.
Mohadeseh Ahmadi et al.
Background: Breast cancer is the most prevalent cancer in women, with post-menopausal diagnoses more common than pre-menopausal. Risk factors for breast cancer include genetics and modifiable factors related to diet, beha...
Securinine bolsters anti-tumor immunity by promoting CD8⁺ T cell activation [0.03%]
Securinine通过促进CD8⁺ T细胞活用来增强抗肿瘤免疫作用
Liangchen Gui,Wenting Song,Haowei Luo et al.
Liangchen Gui et al.
Securinine (SEC) is a natural alkaloid isolated from Flueggea suffruticosa, which can suppress tumor growth of some types. T cells play a critical role in anti-tumor function. However, whether SEC mediates T cell-mediated anti-tumor effects...
Corrigendum to Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformation [0.03%]
卵巢透明细胞癌和子宫内膜异位症共存的转录组景观：恶性转化的新见解的勘误表
Mami Shibata,Yuji Kamei,Keisuke Kawamoto et al.
Mami Shibata et al.
Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study [0.03%]
基线甘油三酯-葡萄糖-体质指数对小细胞肺癌化疗免疫治疗预后价值的多中心回顾性研究
Dongyong Zhu,Yusheng Guo,Weiwei Liu et al.
Dongyong Zhu et al.
Background: The prognostic role of the triglyceride-glucose-body mass index (TyG-BMI), a surrogate marker for insulin resistance, in small cell lung cancer (SCLC) patients treated with immune checkpoint inhibitors remains...
LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinoma [0.03%]
LINC01913和LINC01389作为肾细胞癌早期诊断的新肿瘤标志物
Amirhosein Maharati,Fatemeh Taghavinia,Alireza Golshan et al.
Amirhosein Maharati et al.
Background: Renal cell carcinoma (RCC) ranks as the second most common urological cancer globally. Despite recent progresses, there is a low survival rate for metastatic RCC that is the consequence of advanced stage diagn...
Clinical characteristics and prognostic outcomes in KRAS-mutant non-small cell lung cancer: A real-world study with or without COPD comorbidity [0.03%]
伴有或不伴有慢性阻塞性肺疾病共病的KRAS突变型非小细胞肺癌的临床特征和预后结局：一项真实世界研究
Chen Liao,Yubo Wang,Zhoukui Bi et al.
Chen Liao et al.
Background: Chronic obstructive pulmonary disease (COPD) is the most prevalent comorbidity among lung cancer patients, but its clinical and prognostic relationship with KRAS-mutant non-small cell lung cancer (NSCLC) remai...
Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer [0.03%]
年轻女性 LuminalHER2低表达和HER2超低表达乳腺癌的临床特征及生存预后
Jesus Edgardo Hernandez-Hernandez,César Octavio Lara-Torres,Alejandro Aranda-Gutierrez et al.
Jesus Edgardo Hernandez-Hernandez et al.
Background: Young women with breast cancer (YWBC) often present with aggressive, hormone receptor-positive tumors. However, the implications of HER2-low and HER2-ultralow expression in this group have not been well charac...